Navigation Links
ACE Inhibitors For Vascular Disease Patients

Researchers at the Laval University Heart and Lung Institute in Quebec have found that drugs used to treat heart failure also reduced the risk of death, heart attacks// and stroke in people with hardened arteries and hence should be considered in all vascular disease patients.

ACE inhibitors are drugs that lower blood pressure by inhibiting the formation of a chemical that causes arteries in the body to constrict. They are used to treat heart failure.

In an analysis of three major studies, they found that two out of the three studies involving nearly 30,000 people clearly showed such a benefit. The two studies that showed benefits looked at the incidence of heart attacks, stroke and overall deaths from heart disease, while the third study also looked at the incidence of procedures such as angioplasty in patients with atherosclerosis.

Kim Fox, a professor of clinical cardiology at Royal Brompton Hospital in London and a co-author of the report said that ACE inhibitors should be considered in all vascular disease patients.

Dr. Gilles R. Dagenais, a member of the research team said ACE inhibitors should be prescribed "for patients who have coronary heart disease and also atherosclerosis in major arteries, such as those in the brain, if there are no contraindications and if the physician judges there is benefit.”

However, two Italian Cardiologist have argued against the use of ACE inhibitors in such cases pointing to the results of the third study, which was not favorable.

Though the use of ACE inhibitors to reduce risk of vascular disease is debatable, Dr. Gary Francis, Head of the Cleveland Clinic Clinical cardiology section said that the Canadian interpretation was probably correct as it was done by a group highly qualified to do such studies.

Francis said, but "like all meta-analyses, it has some problems. It would be naive to believe that a meta-analysis would have power ov er a randomized, controlled study,"

He also said still "I have a low threshold to go to ACE inhibitors because there is a low price to pay for their benefits. They should be considered for all patients with atherosclerosis.”


'"/>




Related medicine news :

1. Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence
2. LipB Protein Inhibitors Help To Fight Against TB
3. Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer
4. Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer
5. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
6. Drug Effective for Vascular Dementia
7. New Ways To Treat Vascular Birthmarks
8. Is Aricept, the Alzheimer’s Drug Safe to Use against Vascular Dementia
9. Blood Clots, A Common Feature Of Vascular Dementia And Alzheimers
10. Vascular Disease 101: Discovering and Treating Common Diseases of the Veins
11. People Under 60 At Risk Of Premature Peripheral Vascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital ... the Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital ... the nation. While many providers are struggling to leverage limited resources and technology, Onslow ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, ... expected to grow at a CAGR of 9.4% from 2017-2022 and ... at a CAGR of 9.5% from 2017 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology: